Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by KREPPEL, H.
Right arrow Articles by JONES, M. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KREPPEL, H.
Right arrow Articles by JONES, M. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press

research-article

Antidotal Efficacy of Newly Synthesized Dimercaptosuccinic Acid (DMSA) Monoesters in Experimental Arsenic Poisoning in Mice

HELMUT KREPPEL*,1, FRANZ X. REICHL{dagger}, ANDREAS KLEINE*, LADISLAUS SZINICZ*, PRAMOD K. SINGH{ddagger} and MARK M. JONES{ddagger}

*Institut fuer Pharmakologie und Toxikologie BSW, Sanitaetsakademie der Bundeswehr, Ingolstaedter Landstrasse 100, D-85748 Garching, Germany {dagger}Walther Straub-Institut fuer Pharmakologie und Toxikologie, Universitaet Muenchen Nussbaumstrasse 26, D-80336 Muenchen, Germany {ddagger}Department of Chemistry, Vanderbilt University Box 1583, Station B, Nashville, Tennessee 37235

Received September 6, 1994; accepted December 12, 1994

The efficacy of four newly synthesized monoesters of meso-2,3-dimercaptosuccinic acid (DMSA), mono-i-arnyl- (Mi-ADMS), mono-n-amyl- (Mn-ADMS), mono-i-butyl- (Mi-BDMS), and mono-n-butyl-meso-2,3-dimercaptosuccinate (Mn-BDMS) in increasing survival and arsenic elimination in experimental arsenic poisoning was investigated. Male mice (strain NMRI) received arsenite sc (survival study: 130 µmol/kg, 7 mice/group; elimination study: 85 µmol/kg (LD5) together with a tracer dose of73 As(III), 6 mice/group). After 30 min mice were treated with 0.7 mmol/kg of DMSA or a monoester ip or via gastric tube (ig). Control animals received saline ip. In the survival study mice were observed for 30 days. In the elimination study, the 73-arsenic content of several organs (blood, liver, heart, lung, kidneys, spleen, testes, brain, small intestine, large intestine, muscle, and skin) was measured 0.5, 2, 4, 6, and 8 hr after the arsenic injection using a gamma counter. Survival increased correspondingly well with the increase of arsenic elimination. DMSA, Mi-ADMS, Mn-ADMS, Mi-BDMS, and Mn-BDMS markedly decreased arsenic content in most organs as soon as 1.5 hr after treatment. Only in small and large intestine were higher arsenic amounts found, indicating a shift in arsenic elimination from the renal to the fecal route, and thereby suggesting a protective effect for the kidneys. Given ip, the monoesters turned out to be similarly as effective as the parent drug DMSA. Following ig treatment, the DMSA monoesters Mi-ADMS and Mn ADMS seemed to be superior to DMSA with regard to survival. The similar efficacy of the various monoesters indicates that the side chain substitution did not markedly change bioavailabilty and efficacy. It is concluded that the new DMSA monoesters are effective arsenic antidotes given systemically or orally.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.